EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 13,867,100,000 US dollars
- Current assets
- 6,818,900,000 US dollars
- Non-current assets
- 7,048,200,000 US dollars
- Liabilities
- 3,142,200,000 US dollars
- Current liabilities
- 1,507,900,000 US dollars
- Non-current liabilities
- 1,634,300,000 US dollars
- Equity
- 10,724,900,000 US dollars
- Noncontrolling interest
- 106,900,000 US dollars. Included in consolidated equity; this amount is not added again.
- Cash and cash equivalents
- 2,906,500,000 US dollars
- Short-term investments (Note 5)
- 1,346,200,000 US dollars
- Inventories (Note 2)
- 1,131,200,000 US dollars
- Accounts receivable, net of allowances of $16.0 and $15.0, respectively
- 770,400,000 US dollars
- Other current assets
- 360,300,000 US dollars
- Other receivables
- 185,300,000 US dollars
- Prepaid expenses
- 119,000,000 US dollars
- Goodwill
- 1,951,200,000 US dollars
- Property, plant, and equipment, net
- 1,841,800,000 US dollars
- Other intangible assets, net
- 1,382,600,000 US dollars
- Deferred income taxes
- 911,800,000 US dollars
- Other assets (Note 2)
- 616,400,000 US dollars
- Long-term investments (Note 5)
- 244,100,000 US dollars
- Operating lease right-of-use assets
- 100,300,000 US dollars
- Accrued and other liabilities (Note 2)
- 1,273,300,000 US dollars
- Accounts payable
- 210,500,000 US dollars
- Operating lease liabilities
- 24,100,000 US dollars
- Long-term debt
- 598,700,000 US dollars
- Uncertain tax positions
- 572,200,000 US dollars
- Other liabilities
- 381,800,000 US dollars
- Operating lease liabilities
- 81,600,000 US dollars
- Retained earnings
- 14,863,100,000 US dollars
- Additional paid-in capital
- 2,975,900,000 US dollars
- Common stock, $1.00 par value, 1,050.0 shares authorized, 661.7 and 658.7 shares issued, and 576.6 and 580.7 shares outstanding, respectively
- 661,700,000 US dollars
- Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding
- 0 US dollars
- Noncontrolling interest
- 106,900,000 US dollars
- Treasury stock, at cost, 85.1 and 78.0 shares, respectively
- negative 7,668,100,000 US dollars
- Accumulated other comprehensive loss (Note 13)
- negative 214,600,000 US dollars
- Gross equity (calculated)
- 18,607,600,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
